Anti-HER2 (Trastuzumab)
To Order Contact us: stephen@expresspharmapulse.com
Anti-ERBB2 (Trastuzumab)-SPP-DM1 ADC |
ADC-W-416 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a SPP linker to a DM1 |
Anti-ERBB2 (Trastuzumab)-VC-DUBA ADC |
ADC-W-514 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab) conjugated via a VC linker to DUBA |
Anti-ERBB2 (Trastuzumab)-Mc-MMAF ADC |
ADC-W-549 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab) conjugated via a Mc linker to MMAF |
Anti-ERBB2 (Trastuzumab)-SPDB-DM4 ADC |
ADC-W-2595 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a SPDB linker to DM4 |
Anti-ERBB2 (Trastuzumab)-mpeo-DM1 ADC |
ADC-W-411 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a mpeo linker to a DM1 |
Anti-ERBB2 (Trastuzumab)-SPDP-DM1 ADC |
ADC-W-415 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a SPDP linker to a DM1 |
Anti-ERBB2 (Trastuzumab)-DBM-MMAF ADC |
ADC-W-547 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab) conjugated via a DBM linker to MMAF |
BioSim? Trastuzumab (Herceptin®)(Human) ELISA Kit |
E4376-100 |
Biovision |
each |
EUR 1599.6 |
Anti-ERBB2 (Trastuzumab)-SSNPP-DM3 ADC |
ADC-W-417 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a SSNPP linker to a DM3 |
Anti-ERBB2 (Trastuzumab)-SSNPP-DM4 ADC |
ADC-W-418 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a SSNPP linker to a DM4 |
Anti-ERBB2 (Trastuzumab) Fab -Porphyrin ADC |
ADC-W-420 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of a Fab fragment of anti-ERBB2 monoclonal antibody (Trastuzumab) conjugated via a linker to a Porphyrin |
Anti-ERBB2 (trastuzumab)-AcLysGly-MMAD ADC |
ADC-W-633 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an engineerd anti-ERBB2 antibody (trastuzumab with LLQGG tag at Fc) conjugated via a AcLysGly linker to MMAD |
Anti-ERBB2 (Trastuzumab)-vc-PAB-MMAE ADC |
ADC-W-117 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab) conjugated via a vc-PAB linker to MMAE |
Anti-ERBB2 (Trastuzumab-Fab)-SPP-DM1 ADC |
ADC-W-572 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of a Fab of anti-ERBB2 monoclonal antibody (Trastuzumab) conjugated via a SPP linker to DM1 |
Anti-ERBB2 (Trastuzumab)-SPDP-KG6E-AF ADC |
ADC-W-407 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a SPDP-KG6E linker to a AF |
Anti-ERBB2 (Trastuzumab)-NGM-doxorubicin ADC |
ADC-W-412 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a NGM linker to adoxorubicin |
Anti-ERBB2 (Trastuzumab)-SMCC-maytansine ADC |
ADC-W-510 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab) conjugated via a SMCC linker to maytansine |
Anti-ERBB2 (Trastuzumab)-bisAlk-VC-MMAE ADC |
ADC-W-405 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a bisAlk-VC linker to a MMAE |
Anti-ERBB2(Trastuzumab)-VC-Duostatin-3 ADC |
ADC-W-530 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab) conjugated via a VC linker to Duostatin-3 |
Anti-ERBB2 (trastuzumab)-Aminocaproyl-MMAE ADC |
ADC-W-627 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an engineerd anti-ERBB2 antibody (trastuzumab with LLQGG tag at Fc) conjugated via a Aminocaproyl linker to MMAE |
Anti-ERBB2 (trastuzumab)-Aminocaproyl-MMAD ADC |
ADC-W-632 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an engineerd anti-ERBB2 antibody (trastuzumab with LLQGG tag at Fc) conjugated via a Aminocaproyl linker to MMAD |
Anti-ERBB2 (trastuzumab)-Aminocaproyl-MMAF ADC |
ADC-W-635 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an engineerd anti-ERBB2 antibody (trastuzumab with LLQGG tag at Fc) conjugated via a Aminocaproyl linker to MMAF |
Anti-ERBB2 (trastuzumab)-Aminocaproyl-MMAF ADC |
ADC-W-643 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 antibody (trastuzumab) conjugated via a Aminocaproyl linker to MMAF |
Anti-ERBB2 (Trastuzumab)-Gly5-modified DM1 ADC |
ADC-W-116 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab) conjugated via a linker to modified DM1 |
Anti-ERBB2 (Trastuzumab) Fab -PEG-porphyrin ADC |
ADC-W-421 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of a Fab fragment of anti-ERBB2 monoclonal antibody (Trastuzumab) conjugated via a PEG linker to a Porphyrin |
Anti-ERBB2 (Trastuzumab)-thioether SMCC-DM1 ADC |
ADC-W-414 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a hioether SMCC linker to a DM1 |
Anti-ERBB2 (Trastuzumab)-MC-Vc-PAB-SN38 ADC |
ADC-W-2596 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a MC-Vc-PAB linker to SN38 |
Anti-ERBB2 (Trastuzumab)-Mc-MMAE (Thiol MMAE) ADC |
ADC-W-391 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a Mc linker to a MMAE (Thiol MMAE) |
Shikari (Q-TRAS) Trastuzumab (Herceptin, Herclon)Free drug ELISA kit |
TRA-FD-HH |
Matriks Biotek |
1x96-wells test plate |
EUR 971.7 |
Description: Enzyme Immunoassay for detection of freeTrastuzumab (Herceptin, Herclon) in human serum and plasma samples. |
Custom Testing of Samples for Herceptin/Trastuzumab by ELISA |
200-510-CUX |
Alpha Diagnostics |
Custom |
Ask for price |
Anti-ERBB2 (Trastuzumab-HC-K121)-DBCO-MMAF ADC |
ADC-W-242 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab variant, HC-K121) conjugated via a DBCO linker to MMAF |
Anti-ERBB2 (Trastuzumab-HC-Y180)-DBCO-MMAF ADC |
ADC-W-243 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab variant, HC-Y180) conjugated via a DBCO linker to MMAF |
Anti-ERBB2 (Trastuzumab-HC-K133)-DBCO-MMAF ADC |
ADC-W-244 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab variant, HC-K133) conjugated via a DBCO linker to MMAF |
Anti-ERBB2 (Trastuzumab-HC-S157)-DBCO-MMAF ADC |
ADC-W-245 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab variant, HC-S157) conjugated via a DBCO linker to MMAF |
Anti-ERBB2 (Trastuzumab-HC-F126)-DBCO-MMAF ADC |
ADC-W-246 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab variant, HC-F126) conjugated via a DBCO linker to MMAF |
Anti-ERBB2 (Trastuzumab-HC-P127)-DBCO-MMAF ADC |
ADC-W-247 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab variant,HC-P127) conjugated via a DBCO linker to MMAF |
Anti-ERBB2 (Trastuzumab-LC-R142)-DBCO-MMAF ADC |
ADC-W-254 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab variant,LC-R142) conjugated via a DBCO linker to MMAF |
Anti-ERBB2 (Trastuzumab-LC-N152)-DBCO-MMAF ADC |
ADC-W-255 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab variant,LC-N152) conjugated via a DBCO linker to MMAF |
Anti-ERBB2 (Trastuzumab-LC-Q147)-DBCO-MMAF ADC |
ADC-W-256 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab variant,LC-Q147) conjugated via a DBCO linker to MMAF |
Anti-ERBB2 (Trastuzumab-LC-E161)-DBCO-MMAF ADC |
ADC-W-257 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab variant,LC-E161) conjugated via a DBCO linker to MMAF |
Anti-ERBB2 (Trastuzumab-LC-K149)-DBCO-MMAF ADC |
ADC-W-258 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab variant,LC-K149) conjugated via a DBCO linker to MMAF |
Shikari (S-ATR) Trastuzumab (Herceptin, Herclon) Quantitative ELISA kit |
TRA-QLS-HH |
Matriks Biotek |
1x96-wells test plate |
EUR 999 |
Description: Enzyme Immunoassay for Quantitative detection of Trastuzumab (Herceptin, Herclon) in human serum and plasma samples. |
Anti-ERBB2 (Trastuzumab) Fab-bisAlk-VC-MMAE ADC |
ADC-W-404 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody Fab conjugated via a bisAlk-VC linker to a MMAE |
Anti-ERBB2 (trastuzumab)-AcLys-VC-PABC-MMAD ADC |
ADC-W-631 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an engineerd anti-ERBB2 antibody (trastuzumab with LLQGG tag at Fc) conjugated via a AcLys-VC-PABC linker to MMAD |
Anti-ERBB2 (Trastuzumab)-AO-Mc-MMAE (Glyco MMAE) ADC |
ADC-W-392 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a AO-Mc linker to a MMAE (Glyco MMAE) |
Herceptin/Trastuzumab ELISA Kit for human, 96 tests, quantitative |
200-510-HLG |
Alpha Diagnostics |
1 Kit |
EUR 1365.6 |
Anti-ERBB2 (Trastuzumab)-Mc-PEG8-Dol10 (Thiol Dol10) ADC |
ADC-W-389 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a Mc-PEG8 linker to aDol10 (Thiol Dol10) |
Anti-ERBB2 (trastuzumab)-Amino-PEG2-Propionyl-MMAE ADC |
ADC-W-628 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an engineerd anti-ERBB2 antibody (trastuzumab with LLQGG tag at Fc) conjugated via a Amino-PEG2-Propionyl linker to MMAE |
Anti-ERBB2 (trastuzumab)-Amino-PEG3-Propionyl-MMAE ADC |
ADC-W-629 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an engineerd anti-ERBB2 antibody (trastuzumab with LLQGG tag at Fc) conjugated via a Amino-PEG3-Propionyl linker to MMAE |
Anti-ERBB2 (trastuzumab)-Aminocapropyl-VC-PABC-MMAE ADC |
ADC-W-630 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an engineerd anti-ERBB2 antibody (trastuzumab with LLQGG tag at Fc) conjugated via a Aminocapropyl-VC-PABC linker to MMAE |
Anti-ERBB2 (trastuzumab)-Aminocapropyl-VC-PABC-MMAF ADC |
ADC-W-636 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an engineerd anti-ERBB2 antibody (trastuzumab with LLQGG tag at Fc) conjugated via a Aminocapropyl-VC-PABC linker to MMAF |
Anti-ERBB2 (trastuzumab)-Aminocapropyl-VC-PABC-MMAE ADC |
ADC-W-642 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 antibody (trastuzumab) conjugated via a Aminocaproyl-VC-PABC linker to MMAE |
Anti-ERBB2 (trastuzumab)-Aminocapropyl-VC-PABC-MMAF ADC |
ADC-W-644 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 antibody (trastuzumab) conjugated via a Aminocaproyl-VC-PABC linker to MMAF |
Anti-ERBB2 (Trastuzumab)-AO-Mc-PEG8-Dol10 (Glyco Dol10) ADC |
ADC-W-390 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a AO-Mc-PEG8 linker to aDol10 (Thiol Dol10) |
Anti-ERBB2 (Trastuzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC |
ADC-W-2597 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a MC-Vc-PAB-DMEA-(PEG2) linker to duocarmycin SA |
Human Anti-Herceptin/Trastuzumab Antibody (ADA) ELISA Kit, 96 tests, quantitative |
200-520-HAG |
Alpha Diagnostics |
1 Kit |
EUR 1365.6 |
Herceptin/Trastuzumab identification/Counterfeit detection ELISA Kit, 24 tests, quantitative |
200-515-ID24 |
Alpha Diagnostics |
1 kit |
EUR 634.8 |
Anti-ERBB2 (Trastuzumab)-hydroxyl amino PEG linker-MMAD (monomethyl auristatin D) ADC |
ADC-W-413 |
Creative Biolabs |
1mg |
Ask for price |
Description: This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a hydroxyl amino PEG linker to a MMAD |
anti- HER2/ErbB2 antibody |
FNab03833 |
FN Test |
100µg |
EUR 658.5 |
|
Description: Antibody raised against HER2/ErbB2 |
anti- HER2/ErbB2 antibody |
FNab03834 |
FN Test |
100µg |
EUR 702 |
|
Description: Antibody raised against HER2/ErbB2 |
anti- HER2/ErbB2 antibody |
FNab03835 |
FN Test |
100µg |
EUR 702 |
|
Description: Antibody raised against HER2/ErbB2 |
Anti- Her2/Neu Antibody (IHC002) |
A1519-50 |
Biovision |
each |
EUR 288 |
Anti-ErbB2 (HER2) Monoclonal Antibody |
M00010-1 |
BosterBio |
100ug |
EUR 476.4 |
Description: Rabbit Monoclonal ErbB2 (HER2) Antibody. Validated in IP, IF, IHC, WB and tested in Human. |
HER2 antibody |
10R-1924 |
Fitzgerald |
100 ul |
EUR 418.8 |
Description: Mouse monoclonal HER2 antibody |
HER2 antibody |
20R-1935 |
Fitzgerald |
50 ug |
EUR 337.2 |
Description: Rabbit polyclonal HER2 antibody |
HER2 antibody |
20R-1936 |
Fitzgerald |
50 ug |
EUR 337.2 |
Description: Rabbit polyclonal HER2 antibody |
HER2 antibody |
20R-1939 |
Fitzgerald |
50 ug |
EUR 337.2 |
Description: Rabbit polyclonal HER2 antibody |
HER2 antibody |
20R-2251 |
Fitzgerald |
50 ug |
EUR 337.2 |
Description: Rabbit polyclonal HER2 antibody |
HER2 antibody |
20R-2252 |
Fitzgerald |
50 ug |
EUR 337.2 |
Description: Rabbit polyclonal HER2 antibody |
HER2 antibody |
20R-2253 |
Fitzgerald |
50 ug |
EUR 337.2 |
Description: Rabbit polyclonal HER2 antibody |
HER2 antibody |
70R-33614 |
Fitzgerald |
100 ug |
EUR 392.4 |
Description: Rabbit polyclonal HER2 antibody |
HER2 antibody |
70R-33615 |
Fitzgerald |
100 ug |
EUR 392.4 |
Description: Rabbit polyclonal HER2 antibody |
HER2 antibody |
70R-33783 |
Fitzgerald |
100 ug |
EUR 392.4 |
Description: Rabbit polyclonal HER2 antibody |
HER2 antibody |
70R-37510 |
Fitzgerald |
100 ug |
EUR 327.6 |
Description: Rabbit Polyclonal HER2 antibody |
HER2 antibody |
70R-37511 |
Fitzgerald |
100 ug |
EUR 327.6 |
Description: Rabbit Polyclonal HER2 antibody |
HER2 antibody |
70R-37512 |
Fitzgerald |
100 ug |
EUR 327.6 |
Description: Rabbit Polyclonal HER2 antibody |
HER2 antibody |
70R-51534 |
Fitzgerald |
100 ul |
EUR 292.8 |
Description: Purified Polyclonal HER2 antibody |
HER2 antibody |
70R-34175 |
Fitzgerald |
100 ug |
EUR 392.4 |
Description: Rabbit polyclonal HER2 antibody |
HER2 antibody |
70R-34177 |
Fitzgerald |
100 ug |
EUR 392.4 |
Description: Rabbit polyclonal HER2 antibody |
HER2 antibody |
70R-34179 |
Fitzgerald |
100 ug |
EUR 392.4 |
Description: Rabbit polyclonal HER2 antibody |
HER2 Antibody |
F50601-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
Description: HER2/ErbB2, a member of the EGF receptor family, is an essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. This protein is not activated by EGF, TGF-alpha and amphiregulin. ErbB2 potentially forms a heterodimer with each of the other ERBB receptors. An interaction with PRKCABP has been suggested. Ligand-binding to this Type I membrane protein may increase phosphorylation on tyrosine residues. |
HER2 Antibody |
F50602-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
Description: ErbB2, a member of the EGF receptor family, is an essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. This protein is not activated by EGF, TGF-alpha and amphiregulin. ErbB2 potentially forms a heterodimer with each of the other ERBB receptors. An interaction with PRKCABP has been suggested. Ligand-binding to this Type I membrane protein may increase phosphorylation on tyrosine residues. |
HER2 Antibody |
F52968-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
Description: Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization. |
HER2 Antibody |
R35134-100UG |
NSJ Bioreagents |
100 ug |
EUR 339.15 |
Description: Additional name(s) for this target protein: ERBB2, v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, CD340; ERBB2 |
Aptide scaffold protein anti-Human HER2 |
SAP-L048 |
Creative Biolabs |
1 mg |
EUR 5395.2 |
Description: Scaffold protein |
Her2/Neu Antibody |
P1002-01m |
SAB |
0.1m |
EUR 250.8 |
Her2/Neu Antibody |
P1002-1ml |
SAB |
1ml |
EUR 1268.4 |
HER2 / ErbB2 Antibody |
abx233833-100ug |
Abbexa |
100 ug |
EUR 610.8 |
|
HER2 / ErbB2 Antibody |
abx233834-100ug |
Abbexa |
100 ug |
EUR 661.2 |
|
HER2 / ErbB2 Antibody |
abx233835-100ug |
Abbexa |
100 ug |
EUR 661.2 |
|
HER2 (pT686) Antibody |
abx215219-100ug |
Abbexa |
100 ug |
EUR 526.8 |
|
HER2/ErbB2 Antibody |
AF7679 |
Affbiotech |
200ul |
EUR 540 |
HER2/ErbB2 Antibody |
AF7680 |
Affbiotech |
200ul |
EUR 540 |
HER2/ErbB2 Antibody |
AF7681 |
Affbiotech |
200ul |
EUR 540 |
HER2/ErbB2 Antibody |
AF7682 |
Affbiotech |
200ul |
EUR 540 |
HER2/ErbB2 Antibody |
3783-100 |
Biovision |
each |
EUR 379.2 |
Human HER2 Antibody |
abx023907-100ug |
Abbexa |
100 ug |
EUR 543.6 |
|
HER2/ErbB2 Antibody |
AF6069 |
Affbiotech |
200ul |
EUR 420 |
HER2/ErbB2 Antibody |
AF6070 |
Affbiotech |
200ul |
EUR 420 |
HER2/ErbB2 Antibody |
AF6071 |
Affbiotech |
200ul |
EUR 420 |
Her2/ErbB2 Antibody |
48245-100ul |
SAB |
100ul |
EUR 399.6 |
Her2/ErbB2 Antibody |
48245-50ul |
SAB |
50ul |
EUR 286.8 |
HER2 / ErbB2 Antibody |
48493-100ul |
SAB |
100ul |
EUR 399.6 |
HER2 / ErbB2 Antibody |
48493-50ul |
SAB |
50ul |
EUR 286.8 |
HER2 (pY877) Antibody |
abx012005-100ug |
Abbexa |
100 ug |
EUR 526.8 |
|
HER2 Antibody / ErbB2 |
R20258-0.1ML |
NSJ Bioreagents |
0.1ml |
EUR 347.65 |
Description: This recombinant HER2 antibody reacts to Human c-erbB-2/HER-2. It may also react to mouse or rat c-erbB-2/HER-2, as predicted by immunogen homology. |
HER2 / ErbB 2Antibody |
R32662 |
NSJ Bioreagents |
100ug |
EUR 356.15 |
Description: Receptor tyrosine-protein kinase erbB-2, also known as CD340 (cluster of differentiation 340), proto-oncogene Neu, Erbb2 (rodent), or ERBB2 (human), is a protein that in humans is encoded by the ERBB2 gene. And it is also frequently called HER2 (from human epidermal growth factor receptor 2) or HER2/neu. This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized. |
HER2 Antibody / ErbB2 |
RQ5055 |
NSJ Bioreagents |
100ul |
EUR 356.15 |
Description: The ERBB2 gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. [RefSeq] |
HER2 Antibody / ErbB2 |
V3835-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: HER2/ErbB2 is a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. ErbB2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. [RefSeq] |
HER2 Antibody / ErbB2 |
V3835-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: HER2/ErbB2 is a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. ErbB2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. [RefSeq] |
HER2 Antibody / ErbB2 |
V3835SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: HER2/ErbB2 is a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. ErbB2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. [RefSeq] |
HER2 Antibody / ErbB2 |
V3838-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Recognizes a protein of 185kDa, which is identified as c-erbB-2/HER-2/neu. Its epitope is localized in the extracellular domain. C-erbB-2/HER-2 is a member of the EGFR family. This mAb is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. c-erbB-2/HER-2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V3838-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: Recognizes a protein of 185kDa, which is identified as c-erbB-2/HER-2/neu. Its epitope is localized in the extracellular domain. C-erbB-2/HER-2 is a member of the EGFR family. This mAb is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. c-erbB-2/HER-2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V3838SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Recognizes a protein of 185kDa, which is identified as c-erbB-2/HER-2/neu. Its epitope is localized in the extracellular domain. C-erbB-2/HER-2 is a member of the EGFR family. This mAb is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. c-erbB-2/HER-2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V3839-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Recognizes a protein of 185kDa, which is identified as c-erbB-2/HER-2/neu. Its epitope is localized in the extracellular domain. C-erbB-2/HER-2 is a member of the EGFR family. This mAb is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. c-erbB-2/HER-2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V3839-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: Recognizes a protein of 185kDa, which is identified as c-erbB-2/HER-2/neu. Its epitope is localized in the extracellular domain. C-erbB-2/HER-2 is a member of the EGFR family. This mAb is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. c-erbB-2/HER-2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V3839SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Recognizes a protein of 185kDa, which is identified as c-erbB-2/HER-2/neu. Its epitope is localized in the extracellular domain. C-erbB-2/HER-2 is a member of the EGFR family. This mAb is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. c-erbB-2/HER-2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V7074-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: HER2 is a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. HER2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. [RefSeq] |
HER2 Antibody / ErbB2 |
V7074-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: HER2 is a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. HER2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. [RefSeq] |
HER2 Antibody / ErbB2 |
V7074SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: HER2 is a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. HER2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. [RefSeq] |
HER2 Antibody / ErbB2 |
V2108-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to HER2 / ErbB2 and shows minimal cross-reaction with other members of the family. HER2 is a member of the EGFR family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. HER2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V2108-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This mAb is specific to HER2 / ErbB2 and shows minimal cross-reaction with other members of the family. HER2 is a member of the EGFR family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. HER2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V2108SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This mAb is specific to HER2 / ErbB2 and shows minimal cross-reaction with other members of the family. HER2 is a member of the EGFR family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. HER2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V2109-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes a protein of 185kDa, which is identified as HER2 / ErbB2. Its epitope is localized in the extracellular domain. ErbB2 is a member of the EGFR family. This antibody is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. ErbB2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V2109-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This antibody recognizes a protein of 185kDa, which is identified as HER2 / ErbB2. Its epitope is localized in the extracellular domain. ErbB2 is a member of the EGFR family. This antibody is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. ErbB2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V2109CF488-100T |
NSJ Bioreagents |
100 Tests |
EUR 349.3 |
Description: Recognizes a protein of 185kDa, which is identified as c-erbB-2/HER-2/neu. Its epitope is localized in the extracellular domain. C-erbB-2/HER-2 is a member of the EGFR family. This MAb is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. C-erbB-2/HER-2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V2109SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes a protein of 185kDa, which is identified as HER2 / ErbB2. Its epitope is localized in the extracellular domain. ErbB2 is a member of the EGFR family. This antibody is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. ErbB2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V2110-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes a protein of 185kDa, which is identified as HER2 / ErbB2. Its epitope is localized in the extracellular domain. HER2 is a member of the EGFR family. This antibody is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. HER2 / ErbB2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V2110-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This antibody recognizes a protein of 185kDa, which is identified as HER2 / ErbB2. Its epitope is localized in the extracellular domain. HER2 is a member of the EGFR family. This antibody is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. HER2 / ErbB2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V2110SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes a protein of 185kDa, which is identified as HER2 / ErbB2. Its epitope is localized in the extracellular domain. HER2 is a member of the EGFR family. This antibody is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. HER2 / ErbB2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V2111-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes a protein of 185kDa, which is identified as HER2 / ErbB2. Its epitope is localized in the extracellular domain. HER2 is a member of the EGFR family. This antibody is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. HER2 / ErbB2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V2111-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This antibody recognizes a protein of 185kDa, which is identified as HER2 / ErbB2. Its epitope is localized in the extracellular domain. HER2 is a member of the EGFR family. This antibody is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. HER2 / ErbB2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V2111SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes a protein of 185kDa, which is identified as HER2 / ErbB2. Its epitope is localized in the extracellular domain. HER2 is a member of the EGFR family. This antibody is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. HER2 / ErbB2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V2377-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: ErbB2, also called HER2, is a member of the EGFR family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. This ErbB2 antibody shows minimal cross-reaction with other members of the family. The protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V2377-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: ErbB2, also called HER2, is a member of the EGFR family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. This ErbB2 antibody shows minimal cross-reaction with other members of the family. The protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V2377SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: ErbB2, also called HER2, is a member of the EGFR family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. This ErbB2 antibody shows minimal cross-reaction with other members of the family. The protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V2378-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes a protein of 185kDa, which is identified as HER2 / ErbB2. Its epitope is localized in the extracellular domain. HER2 is a member of the EGFR family. This antibody is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. HER2 / ErbB2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V2378-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This antibody recognizes a protein of 185kDa, which is identified as HER2 / ErbB2. Its epitope is localized in the extracellular domain. HER2 is a member of the EGFR family. This antibody is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. HER2 / ErbB2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V2378SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody recognizes a protein of 185kDa, which is identified as HER2 / ErbB2. Its epitope is localized in the extracellular domain. HER2 is a member of the EGFR family. This antibody is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. HER2 / ErbB2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V7407-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Recognizes a protein of 185kDa, which is identified as c-erbB-2/HER-2/neu. Its epitope is localized in the extracellular domain. C-erbB-2/HER-2 is a member of the EGFR family. This mAb is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. c-erbB-2/HER-2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V7407-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: Recognizes a protein of 185kDa, which is identified as c-erbB-2/HER-2/neu. Its epitope is localized in the extracellular domain. C-erbB-2/HER-2 is a member of the EGFR family. This mAb is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. c-erbB-2/HER-2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V7407IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: Recognizes a protein of 185kDa, which is identified as c-erbB-2/HER-2/neu. Its epitope is localized in the extracellular domain. C-erbB-2/HER-2 is a member of the EGFR family. This mAb is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. c-erbB-2/HER-2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V7407SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Recognizes a protein of 185kDa, which is identified as c-erbB-2/HER-2/neu. Its epitope is localized in the extracellular domain. C-erbB-2/HER-2 is a member of the EGFR family. This mAb is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. c-erbB-2/HER-2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V7563-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Recognizes a protein of 185kDa, which is identified as c-erbB-2/HER-2/neu. Its epitope is localized in the extracellular domain. C-erbB-2/HER-2 is a member of the EGFR family. This MAb is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. c-erbB-2/HER-2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
HER2 Antibody / ErbB2 |
V7563-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: Recognizes a protein of 185kDa, which is identified as c-erbB-2/HER-2/neu. Its epitope is localized in the extracellular domain. C-erbB-2/HER-2 is a member of the EGFR family. This MAb is specific and shows minimal cross-reaction with other members of the EGFR-family. Receptors of this family are located on the plasma membrane and consist of an extracellular ligand-binding domain that is connected to a large intracellular domain by a single transmembrane sequence. c-erbB-2/HER-2 protein is over-expressed in a variety of carcinomas especially those of breast and ovary. |
Anti-HER2 (Trastuzumab)